GE vs JAZZ · P/E 44, rev $13.35B vs P/E 1988, rev $2.28B
GE Aerospace (GE) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE. It is led by Larry Culp.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported GE revenue for 2026-06-30 was $13.35B. Net income was $2.37B. Revenue was up 7.7% from 2026-03-31 to 2026-06-30. GE currently screens at market cap $373.04B and trailing P/E 44.4.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
GE currently screens at market cap $373.04B and trailing P/E 44.4. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the GE and JAZZ stock pages for the full models.
Not investment advice.